LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Messe Düsseldorf to Promote International “MEDICAlliance” Portfolio at AACC 2022

By LabMedica International staff writers
Posted on 26 Jul 2022
Print article
Image: MEDICA is the No. 1 international medical trade fair worldwide (Photo courtesy of Messe Düsseldorf)
Image: MEDICA is the No. 1 international medical trade fair worldwide (Photo courtesy of Messe Düsseldorf)

Messe Düsseldorf (Düsseldorf, Germany) is participating in the AACC Clinical Lab Expo 2022 in order to promote its “MEDICAlliance” program of regional and international medical trade fairs organized around the globe.

As the No. 1 international medical trade fair worldwide, MEDICA reflects the status of the medical market. Traditionally, MEDICA has featured over 5,000 exhibitors and attracted around 120,000 visitors annually. The exhibitors showcase innovations along the industry's entire value chain and for the complete workflow of modern healthcare. Congresses, various theme parks, forums and numerous special events will complement the exhibits. On average, 800+ international IVD companies and lab equipment manufacturers have participated each year, displaying the latest global advancements in laboratory medicine, equipment, and molecular diagnostic solutions.

At AACC booth 1934, visitor and exhibitor information will be available for MEDICA 2022, World Forum for Medicine, and COMPAMED 2022, High tech solutions for medical technology (held currently from November 14 – 17, 2022 in Düsseldorf, Germany), MEDICAL FAIR ASIA 2022 and MEDICAL MANUFACTURING ASIA 2022 (taking place concurrently from August 31 – September 2, 2022 in Singapore) as well as Medical Fair Thailand (September 13 – 15, 2023 in Bangkok).
 

Related Links:
Messe Düsseldorf

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Coagulation Analyzer
CS-2400
New
Immunofluorescence Analyzer
MPQuanti

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.